SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. Ramle who wrote (377)8/21/1997 12:57:00 PM
From: Biomaven   of 10280
 
As I mentioned in an earlier post, (#373) there have been some developments in the dispute. My guess would be that the earlier decision overturning the Perseptive patents will now be reversed in the light of a new appeals court decision in an unrelated case.

Such a decision would mean that the suit against Biosepra/Sepracor would proceed to the litigation of whether the Perseptive patents were in fact infringed.

I don't think the suit is particularly relevant to SEPR's long term future, and I wish they would settle it. As I mentioned before, I bought some Perseptive calls by way of some insurance - the suit has a much bigger impact on Perseptive than it does on Sepracor.

(Caveat: Although I am a (non-practicing) attorney, my patent law expertise is minimal. Unfortunately, while Harvard Law School offered umpteen courses on 18th century Chinese law and the like, they never saw fit to offer a course in patent law when I was there).

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News